About Cipla Limited
Cipla Limited (CIPLA) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Mumbai, India and employs approximately 30,313 people. With a market capitalization of $1.1 trillion, CIPLA is one of the largest publicly traded companies.
Key Statistics
- Current Price
- ₹1,314.70
- Market Cap
- ₹1.06T
- 52-Week High
- ₹1,673.00
- 52-Week Low
- ₹1,281.70
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -13.01% | ₹1,511.30 | ₹1,314.70 |
| 2025 | -0.10% | ₹1,512.84 | ₹1,511.30 |
| 2024 | +23.72% | ₹1,222.76 | ₹1,512.84 |
| 2023 | +16.77% | ₹1,047.13 | ₹1,222.76 |
| 2022 | +14.52% | ₹914.37 | ₹1,047.13 |
| 2021 | +15.78% | ₹789.78 | ₹914.37 |
| 2020 | +73.26% | ₹455.83 | ₹789.78 |
| 2019 | -7.42% | ₹492.34 | ₹455.83 |
| 2018 | -14.21% | ₹573.90 | ₹492.34 |
| 2017 | +7.36% | ₹534.56 | ₹573.90 |
| 2016 | -12.16% | ₹608.53 | ₹534.56 |
| 2015 | +4.02% | ₹585.02 | ₹608.53 |
| 2014 | +57.00% | ₹372.62 | ₹585.02 |
| 2013 | -2.76% | ₹383.18 | ₹372.62 |
| 2012 | +30.26% | ₹294.16 | ₹383.18 |
| 2011 | -12.92% | ₹337.81 | ₹294.16 |
| 2010 | +11.34% | ₹303.40 | ₹337.81 |
| 2009 | +80.88% | ₹167.74 | ₹303.40 |
| 2008 | -11.49% | ₹189.52 | ₹167.74 |
| 2007 | -14.48% | ₹221.62 | ₹189.52 |
| 2006 | +41.42% | ₹156.71 | ₹221.62 |
| 2005 | +42.39% | ₹110.05 | ₹156.71 |
| 2004 | +22.20% | ₹90.06 | ₹110.05 |
| 2003 | +48.31% | ₹60.73 | ₹90.06 |
| 2002 | -20.15% | ₹76.05 | ₹60.73 |
| 2001 | +9.05% | ₹69.74 | ₹76.05 |
| 2000 | -22.26% | ₹89.70 | ₹69.74 |
| 1999 | +374.03% | ₹18.92 | ₹89.70 |
| 1998 | +35.66% | ₹13.95 | ₹18.92 |
| 1997 | +30.09% | ₹10.72 | ₹13.95 |
Valuation
CIPLA currently trades at a trailing P/E ratio of 23.4, which is considered moderate relative to the broader market. The forward P/E of 23.5 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 3.2. The price-to-sales ratio is 3.8.
Dividends
Cipla Limited pays a dividend to shareholders with a current yield of 0.99%. This translates to $13.00 per share annually. The payout ratio of 23% indicates sustainable dividend coverage.
Risk & Volatility
CIPLA has a beta of -0.04, indicating it is less volatile than the overall market. The stock's 52-week range is $1281.70 to $1673.00, and it currently trades near its 52-week low.
Analyst Ratings
Based on 36 analyst opinions, CIPLA has a consensus "none" rating. The average price target of $1446.31 suggests 10.0% upside from current levels.
Frequently Asked Questions
What does Cipla Limited do? ▼
Cipla Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India.
What sector is CIPLA in? ▼
CIPLA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did CIPLA go public? ▼
Cipla Limited went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in CIPLA 5 years ago be worth today? ▼
A $1,000 investment in CIPLA five years ago would be worth approximately $1,622 today, representing a 62.1% return.
Does CIPLA pay dividends? ▼
Yes, Cipla Limited pays a dividend with a current yield of 0.99%, which is $13.0 per share annually.
What is CIPLA's market cap? ▼
Cipla Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.
What is CIPLA's P/E ratio? ▼
CIPLA has a trailing P/E ratio of 23.4 and a forward P/E of 23.5, which measures how much investors are paying per dollar of earnings.
Is CIPLA a buy, hold, or sell? ▼
Based on 36 opinions, CIPLA has a consensus "none" rating. The average price target is $1446.31.
Last updated: 3/14/2026